Drug
Evofosfamide
Evofosfamide is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_1
3
75%
Ph phase_2
1
25%
Phase Distribution
3
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 2Efficacy & side effects
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Other(1)
Detailed Status
Not yet recruiting1
unknown1
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (75.0%)
Phase 21 (25.0%)
Trials by Status
not_yet_recruiting125%
unknown125%
recruiting125%
completed125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingphase_2
Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer
NCT06836726
recruitingphase_1
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
NCT06782555
completedphase_1
A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer
NCT01833546
unknownphase_1
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
NCT03098160
Clinical Trials (4)
Showing 4 of 4 trials
NCT06836726Phase 2
Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer
NCT06782555Phase 1
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
NCT01833546Phase 1
A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer
NCT03098160Phase 1
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4